Comparison of Immune and Systemic Inflammation Parameters in Patients with a Depressive Episode in Bipolar Disorder and Major Depressive Disorder: A Scoping Review

BACKGROUND: Many studies have aimed to investigate and compare immune system and systemic inflammation parameters in patients with bipolar disorder (BD) and major depressive disorder (MDD) suffering from a depressive episode. However, no systematic review of the results has been conducted so far....

Full description

Saved in:
Bibliographic Details
Main Authors: Anastasia A. Kasyanova, Polina A. Sobolevskaia, Oleg V. Limankin, Nataliia N. Petrova
Format: Article
Language:English
Published: Eco-Vector 2024-12-01
Series:Consortium Psychiatricum
Subjects:
Online Access:https://consortium-psy.com/jour/article/viewFile/15543/pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850110943737937920
author Anastasia A. Kasyanova
Polina A. Sobolevskaia
Oleg V. Limankin
Nataliia N. Petrova
author_facet Anastasia A. Kasyanova
Polina A. Sobolevskaia
Oleg V. Limankin
Nataliia N. Petrova
author_sort Anastasia A. Kasyanova
collection DOAJ
description BACKGROUND: Many studies have aimed to investigate and compare immune system and systemic inflammation parameters in patients with bipolar disorder (BD) and major depressive disorder (MDD) suffering from a depressive episode. However, no systematic review of the results has been conducted so far. AIM: The aim of this study was to conduct a scoping review of research studies comparing immune and systemic inflammation parameters in patients with BD and MDD during a depressive episode. METHODS: The search for studies was conducted in the Medline and eLIBRARY databases for the period from January 1994 to December 2022. Open-access articles written in English and Russian were selected. The review included original studies that compared groups of patients with BD and MDD (diagnosed based on the DSM-IV, DSM-5, or ICD-10 criterion) by immune and systemic inflammation parameters (such as the counts, ratio, and functions of blood cells, erythrocyte sedimentation rate, concentrations of immunoglobulins, cytokines, acute phase proteins, complement components, and autoantibodies). RESULTS: The review included 24 studies. Current depressive episodes in patients with BD were associated with higher concentrations of chemokines (C-C motif chemokine ligand 3 (CCL3), CCL4, CCL5, CCL11), platelet-derived growth factor B, and interleukin 9 (IL-9) (two studies in each case), whereas patients with MDD tended to have higher concentrations of soluble tumor necrosis factor receptor 1 and immunoglobulin G to oxidized low-density lipoproteins (two studies each). Patients with BD and MDD had comparable concentrations of IL-8 (five studies); IL-2 and IL-10 (four studies each); IL-13 and gamma interferon (three studies each); IL-17, IL-1Rα, the vascular endothelial growth factor, as well as white blood cells, monocyte, and platelet counts (two studies each). Contradictory results were obtained for the levels of tumor necrosis factor-α (the concentrations did not differ in five studies, were elevated in BD patients in five studies, were elevated in MDD patients in two studies), IL-6 (the concentrations did not differ in eight studies and were elevated in BD patients in four studies), C-reactive protein (the concentrations did not differ in six studies, were elevated in BD patients in two studies), IL-4 (the concentrations did not differ in three studies and were elevated in MDD patients in two studies), IL-1β and the neutrophil count (the levels did not differ in one study each and were elevated in BD patients in two studies). Several studies have demonstrated an association between immune and systemic inflammation parameters and the severity of depressive and anxiety symptoms, melancholic depression, age of mood disorder onset, body mass index, and imipramine equivalent. CONCLUSION: Some immune and systemic inflammation parameters are associated with a current depressive episode in patients with MDD or BD. These parameters may be considered as potential biomarkers for a differential diagnosis of these disorders.
format Article
id doaj-art-0c71cd3dccfb4404a6aa9c9e2f1b4180
institution OA Journals
issn 2712-7672
2713-2919
language English
publishDate 2024-12-01
publisher Eco-Vector
record_format Article
series Consortium Psychiatricum
spelling doaj-art-0c71cd3dccfb4404a6aa9c9e2f1b41802025-08-20T02:37:43ZengEco-VectorConsortium Psychiatricum2712-76722713-29192024-12-0154647710.17816/CP15543161Comparison of Immune and Systemic Inflammation Parameters in Patients with a Depressive Episode in Bipolar Disorder and Major Depressive Disorder: A Scoping ReviewAnastasia A. Kasyanova0https://orcid.org/0000-0002-8467-5368Polina A. Sobolevskaia1https://orcid.org/0000-0002-0807-1538Oleg V. Limankin2https://orcid.org/0000-0001-6318-7536Nataliia N. Petrova3https://orcid.org/0000-0003-4096-6208Saint Petersburg State UniversitySaint Petersburg State UniversitySaint Petersburg State UniversitySaint Petersburg State UniversityBACKGROUND: Many studies have aimed to investigate and compare immune system and systemic inflammation parameters in patients with bipolar disorder (BD) and major depressive disorder (MDD) suffering from a depressive episode. However, no systematic review of the results has been conducted so far. AIM: The aim of this study was to conduct a scoping review of research studies comparing immune and systemic inflammation parameters in patients with BD and MDD during a depressive episode. METHODS: The search for studies was conducted in the Medline and eLIBRARY databases for the period from January 1994 to December 2022. Open-access articles written in English and Russian were selected. The review included original studies that compared groups of patients with BD and MDD (diagnosed based on the DSM-IV, DSM-5, or ICD-10 criterion) by immune and systemic inflammation parameters (such as the counts, ratio, and functions of blood cells, erythrocyte sedimentation rate, concentrations of immunoglobulins, cytokines, acute phase proteins, complement components, and autoantibodies). RESULTS: The review included 24 studies. Current depressive episodes in patients with BD were associated with higher concentrations of chemokines (C-C motif chemokine ligand 3 (CCL3), CCL4, CCL5, CCL11), platelet-derived growth factor B, and interleukin 9 (IL-9) (two studies in each case), whereas patients with MDD tended to have higher concentrations of soluble tumor necrosis factor receptor 1 and immunoglobulin G to oxidized low-density lipoproteins (two studies each). Patients with BD and MDD had comparable concentrations of IL-8 (five studies); IL-2 and IL-10 (four studies each); IL-13 and gamma interferon (three studies each); IL-17, IL-1Rα, the vascular endothelial growth factor, as well as white blood cells, monocyte, and platelet counts (two studies each). Contradictory results were obtained for the levels of tumor necrosis factor-α (the concentrations did not differ in five studies, were elevated in BD patients in five studies, were elevated in MDD patients in two studies), IL-6 (the concentrations did not differ in eight studies and were elevated in BD patients in four studies), C-reactive protein (the concentrations did not differ in six studies, were elevated in BD patients in two studies), IL-4 (the concentrations did not differ in three studies and were elevated in MDD patients in two studies), IL-1β and the neutrophil count (the levels did not differ in one study each and were elevated in BD patients in two studies). Several studies have demonstrated an association between immune and systemic inflammation parameters and the severity of depressive and anxiety symptoms, melancholic depression, age of mood disorder onset, body mass index, and imipramine equivalent. CONCLUSION: Some immune and systemic inflammation parameters are associated with a current depressive episode in patients with MDD or BD. These parameters may be considered as potential biomarkers for a differential diagnosis of these disorders.https://consortium-psy.com/jour/article/viewFile/15543/pdfdepressive episodebipolar disordermajor depressive disorderdifferential diagnosisimmune systeminflammation
spellingShingle Anastasia A. Kasyanova
Polina A. Sobolevskaia
Oleg V. Limankin
Nataliia N. Petrova
Comparison of Immune and Systemic Inflammation Parameters in Patients with a Depressive Episode in Bipolar Disorder and Major Depressive Disorder: A Scoping Review
Consortium Psychiatricum
depressive episode
bipolar disorder
major depressive disorder
differential diagnosis
immune system
inflammation
title Comparison of Immune and Systemic Inflammation Parameters in Patients with a Depressive Episode in Bipolar Disorder and Major Depressive Disorder: A Scoping Review
title_full Comparison of Immune and Systemic Inflammation Parameters in Patients with a Depressive Episode in Bipolar Disorder and Major Depressive Disorder: A Scoping Review
title_fullStr Comparison of Immune and Systemic Inflammation Parameters in Patients with a Depressive Episode in Bipolar Disorder and Major Depressive Disorder: A Scoping Review
title_full_unstemmed Comparison of Immune and Systemic Inflammation Parameters in Patients with a Depressive Episode in Bipolar Disorder and Major Depressive Disorder: A Scoping Review
title_short Comparison of Immune and Systemic Inflammation Parameters in Patients with a Depressive Episode in Bipolar Disorder and Major Depressive Disorder: A Scoping Review
title_sort comparison of immune and systemic inflammation parameters in patients with a depressive episode in bipolar disorder and major depressive disorder a scoping review
topic depressive episode
bipolar disorder
major depressive disorder
differential diagnosis
immune system
inflammation
url https://consortium-psy.com/jour/article/viewFile/15543/pdf
work_keys_str_mv AT anastasiaakasyanova comparisonofimmuneandsystemicinflammationparametersinpatientswithadepressiveepisodeinbipolardisorderandmajordepressivedisorderascopingreview
AT polinaasobolevskaia comparisonofimmuneandsystemicinflammationparametersinpatientswithadepressiveepisodeinbipolardisorderandmajordepressivedisorderascopingreview
AT olegvlimankin comparisonofimmuneandsystemicinflammationparametersinpatientswithadepressiveepisodeinbipolardisorderandmajordepressivedisorderascopingreview
AT nataliianpetrova comparisonofimmuneandsystemicinflammationparametersinpatientswithadepressiveepisodeinbipolardisorderandmajordepressivedisorderascopingreview